France Bed Holdings (7840) Fundamentals 2026 — P/E 15.5x, Revenue Analysis | SniperIQ
France Bed Holdings (7840) is a JP-listed Healthcare company in Medical - Specialties with a market capitalization of ¥42.6B, trading at ¥1276.00 on the JPX. This SniperIQ fundamentals page covers France Bed Holdings's valuation (P/E 15.5x, P/B 1.1x), profitability (net margin 4.4%), revenue (¥61.8B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is France Bed Holdings's market cap?
France Bed Holdings (7840) has a market capitalization of approximately ¥42.6B, trading at ¥1276.00 on the JPX. Market cap moves with the live share price.
What is France Bed Holdings's P/E ratio?
France Bed Holdings's trailing twelve-month P/E ratio is 15.5x, with a price-to-book (P/B) of 1.1x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is France Bed Holdings?
France Bed Holdings runs a net profit margin of 4.4%, a gross margin of 54.7%, and an operating margin of 7.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does France Bed Holdings generate?
France Bed Holdings reported revenue of ¥61.8B for fiscal year 2025, with net income of ¥2.7B and earnings per share (EPS) of 82.04. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does France Bed Holdings pay a dividend?
France Bed Holdings offers a trailing dividend yield of about 3.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is France Bed Holdings financially healthy?
France Bed Holdings carries a debt-to-equity ratio of 0.43x and a current ratio of 2.60x, with a market beta of 0.22. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is France Bed Holdings a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For France Bed Holdings (7840) the key facts are: market cap ¥42.6B, P/E 15.5x, revenue ¥61.8B, 52-week range 1175-1392. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track France Bed Holdings's full fundamentals live
Get France Bed Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.